Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Implementing Timely Germline Genetic Testing for Patients With Pancreatic Cancer Using a Genetics Copilot for Point-of-Care Education and Health Assessment.

JCO precision oncology·2026

Same author

Enhancing Volumetric Hydrogen Storage Capacity through Bimodal Packing of MOF Particles.

ACS omega·2026

Same author

Trans-arterial gemcitabine micro perfusion of locally advanced pancreatic cancer enabled by coil plus glue embolization of a pancreaticoduodenal branch.

Radiology case reports·2026

Same author

Chronic periodontitis and systemic inflammation in the elderly: implications for neurodegeneration.

Journal of neuroinflammation·2026

Same author

Neuroprotective Effects of PEP-1-PGAM5 via the Attenuation of Oxidative Stress and Apoptosis in Parkinson's Disease.

Journal of neurochemistry·2025

Same author

Race-based differences in serum biomarkers for cancer-associated cachexia in a diverse cohort of patients with pancreatic ductal adenocarcinoma.

Communications medicine·2025

Search research articles

Related Experiment Video

Updated: Feb 5, 2026

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

Immunotherapy for uveal melanoma.

Dae Won Kim^1,1, Jaime Anderson^2,2, Sapna P Patel^2,2

¹Moffitt Cancer Center, Tampa, FL 33612, USA.

Melanoma Management

|September 8, 2018

Summary

Uveal melanoma (UM) is a rare eye cancer. This review explores UM

Area of Science:

Ophthalmology
Oncology
Immunology

Background:

Uveal melanoma (UM) is a rare but aggressive eye cancer with poor prognosis.
UM exhibits unique immunological features, including resistance to immunotherapy due to the eye's immunosuppressive environment.
Metastatic UM poses significant challenges for effective treatment, particularly with immunotherapy.

Purpose of the Study:

To review the immunological characteristics of uveal melanoma.
To discuss current clinical data on immunotherapeutic agents and treatment regimens for metastatic UM.
To explore strategies for overcoming immune resistance and enhancing antitumor immunity in UM.

Main Methods:

Literature review of immunological aspects of uveal melanoma.
Analysis of clinical study data for immunotherapeutic agents in metastatic UM.

Keywords:

immunology immunotherapy uveal melanoma

More Related Videos

Generation of a Liver Orthotopic Human Uveal Melanoma Xenograft Platform in Immunodeficient Mice

Generation of a Liver Orthotopic Human Uveal Melanoma Xenograft Platform in Immunodeficient Mice

Published on: November 6, 2019

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Experiment Videos

Last Updated: Feb 5, 2026

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

Generation of a Liver Orthotopic Human Uveal Melanoma Xenograft Platform in Immunodeficient Mice

Generation of a Liver Orthotopic Human Uveal Melanoma Xenograft Platform in Immunodeficient Mice

Published on: November 6, 2019

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Discussion of emerging strategies for improving UM immunotherapy.

Main Results:

Uveal melanoma possesses distinct immune-evasive mechanisms compared to cutaneous melanoma.
Limited clinical data currently exist for novel immunotherapies in metastatic UM.
Strategies to overcome immune suppression in the ocular microenvironment are under investigation.

Conclusions:

Understanding UM's unique immunology is crucial for developing effective treatments.
Further clinical investigation of immunotherapies is needed to improve outcomes for metastatic UM patients.
Targeting immune resistance holds promise for enhancing antitumor responses in uveal melanoma.